Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Custodiol-N versus Custodiol in aortic valve surgery
2012-003776-40Phase 3Completed
- Sponsor
- Franz Köhler Chemie
- Start
- Apr 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of histidine-tryptophan-ketoglutarate solution (modified), HTK Custodiol in aortic valve disease (AVD), sponsored by Franz Köhler Chemie. Started Apr 2013; status: completed.
02
Drugs
histidine-tryptophan-ketoglutarate solution (modified)HTK Custodiol
03
Conditions
aortic valve disease (AVD)
Beyond the preview
Go deeper on 2012-003776-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-003776-40.